• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与三磷酸腺苷(ATP)结合的拓扑异构酶II作为抗肿瘤药物的靶点。

Atp-bound topoisomerase ii as a target for antitumor drugs.

作者信息

Wang H, Mao Y, Zhou N, Hu T, Hsieh T S, Liu L F

机构信息

Department of Pharmacology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.

出版信息

J Biol Chem. 2001 May 11;276(19):15990-5. doi: 10.1074/jbc.M011143200. Epub 2001 Feb 23.

DOI:10.1074/jbc.M011143200
PMID:11278845
Abstract

Topoisomerase II (TOP2) poisons interfere with the breakage/reunion reaction of TOP2 resulting in DNA cleavage. In the current studies, we show that two different classes (ATP-sensitive and -insensitive) of TOP2 poisons can be identified based on their differential sensitivity to the ATP-bound conformation of TOP2. First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected. In addition, ADP was shown to strongly antagonize TOP2-mediated DNA cleavage induced by ATP-sensitive but not ATP-insensitive TOP2 poisons. Second, C427A mutant human TOP2alpha, which exhibits reduced ATPase activity, was shown to exhibit cross-resistance to all ATP-sensitive but not ATP-insensitive TOP2 poisons. Third, using ciprofloxacin competition assay, TOP2-mediated DNA cleavage induced by ATP-sensitive but not ATP-insensitive poisons was shown to be antagonized by ciprofloxacin. These results suggest that ATP-bound TOP2 may be the specific target of ATP-sensitive TOP2 poisons. Using Lac repressor-operator complexes as roadblocks, we show that ATP-bound TOP2 acts as a circular clamp capable of entering DNA ends and sliding on unobstructed duplex DNA.

摘要

拓扑异构酶II(TOP2)毒剂干扰TOP2的断裂/重连反应,导致DNA裂解。在当前研究中,我们表明,基于对TOP2的ATP结合构象的不同敏感性,可以鉴定出两类不同的(对ATP敏感和不敏感的)TOP2毒剂。首先,在存在1 mM ATP或不可水解类似物腺苷5'-(β,γ-亚氨基)三磷酸的情况下,由ATP敏感的TOP2毒剂(如阿霉素、依托泊苷、米托蒽醌和4'-(9-吖啶基氨基)甲磺酰基间茴香胺)诱导的TOP2介导的DNA裂解受到30至100倍的刺激,而由ATP不敏感的TOP2毒剂(如氨萘非特、巴曲霉素和甲萘醌)诱导的DNA裂解仅受到轻微影响(小于3倍)。此外,ADP被证明强烈拮抗由ATP敏感但非ATP不敏感的TOP2毒剂诱导的TOP2介导的DNA裂解。其次,表现出ATP酶活性降低的C427A突变型人TOP2α对所有ATP敏感但非ATP不敏感的TOP2毒剂表现出交叉抗性。第三,使用环丙沙星竞争试验,由ATP敏感但非ATP不敏感的毒剂诱导的TOP2介导的DNA裂解被环丙沙星拮抗。这些结果表明,ATP结合的TOP2可能是ATP敏感的TOP2毒剂的特异性靶点。使用乳糖阻遏物-操纵子复合物作为障碍物,我们表明ATP结合的TOP2作为一种环状夹,能够进入DNA末端并在无阻碍的双链DNA上滑动。

相似文献

1
Atp-bound topoisomerase ii as a target for antitumor drugs.与三磷酸腺苷(ATP)结合的拓扑异构酶II作为抗肿瘤药物的靶点。
J Biol Chem. 2001 May 11;276(19):15990-5. doi: 10.1074/jbc.M011143200. Epub 2001 Feb 23.
2
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.对双二氧哌嗪拓扑异构酶II催化抑制剂ICRF-187具有抗性的人小细胞肺癌NYH细胞,在α同工型的沃克A共有ATP结合结构域中表现出功能性R162Q突变。
Cancer Res. 1999 Jul 15;59(14):3442-50.
3
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.嵌入型 TOP2 毒物在较高浓度时会减弱拓扑异构酶的作用。
Mol Pharmacol. 2019 Oct;96(4):475-484. doi: 10.1124/mol.119.117259. Epub 2019 Aug 9.
4
Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine.细胞ATP耗竭对拓扑异构酶II毒药的影响。依托泊苷可消除可裂解复合物的形成,但安吖啶不能。
Mol Pharmacol. 1999 Mar;55(3):424-31.
5
The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine.酵母拓扑异构酶II的前2至5号突变体编码一种对依托泊苷和安吖啶耐药的酶。
J Biol Chem. 1993 Sep 5;268(25):18586-92.
6
Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms.拓扑异构酶 II 抑制剂通过不同的机制抑制脊椎动物 DNA 复制。
EMBO J. 2022 Jun 14;41(12):e110632. doi: 10.15252/embj.2022110632. Epub 2022 May 16.
7
Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.非同源末端连接途径在拓扑异构酶II介导的DNA损伤存活中的作用。
Mol Cancer Ther. 2006 Jun;5(6):1405-14. doi: 10.1158/1535-7163.MCT-05-0263.
8
Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy.泛素化和 SUMO 化调控拓扑异构酶 II 的稳定性和活性:癌症化疗的临床意义。
Mol Biol Rep. 2021 Sep;48(9):6589-6601. doi: 10.1007/s11033-021-06665-7. Epub 2021 Sep 2.
9
Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide.对抗拓扑异构酶药物具有抗性的酵母拓扑异构酶II突变体:对选择出的对依托泊苷具有抗性的新型酵母拓扑异构酶II突变体的鉴定与表征
Cancer Res. 1994 Jun 1;54(11):2943-51.
10
Mutation of a conserved serine residue in a quinolone-resistant type II topoisomerase alters the enzyme-DNA and drug interactions.喹诺酮耐药性II型拓扑异构酶中一个保守丝氨酸残基的突变改变了酶与DNA及药物的相互作用。
J Biol Chem. 1999 Mar 12;274(11):7292-301. doi: 10.1074/jbc.274.11.7292.

引用本文的文献

1
Predicting Response to Anthracyclines in Ovarian Cancer.预测卵巢癌对蒽环类药物的反应。
Int J Environ Res Public Health. 2022 Apr 2;19(7):4260. doi: 10.3390/ijerph19074260.
2
Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway.褪黑素通过NF-κB途径抑制P-糖蛋白表达,从而增加弥漫性大B细胞淋巴瘤细胞对表柔比星的化疗敏感性。
Transl Oncol. 2021 Jan;14(1):100876. doi: 10.1016/j.tranon.2020.100876. Epub 2020 Sep 29.
3
Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy.
靶向 UHRF1 依赖性 DNA 修复可选择性地增强 KRAS 突变型肺癌对化疗的敏感性。
Cancer Lett. 2020 Nov 28;493:80-90. doi: 10.1016/j.canlet.2020.08.008. Epub 2020 Aug 16.
4
Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma.AXL 转录上调 c-MYC 赋予食管腺癌对表柔比星的耐药性。
Mol Oncol. 2018 Dec;12(12):2191-2208. doi: 10.1002/1878-0261.12395. Epub 2018 Nov 5.
5
Etoposide quinone is a covalent poison of human topoisomerase IIβ.依托泊苷醌是一种人拓扑异构酶 IIβ 的共价毒物。
Biochemistry. 2014 May 20;53(19):3229-36. doi: 10.1021/bi500421q. Epub 2014 May 2.
6
Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance.29 株乳腺癌细胞系在化疗压力下的平行进化导致了不同的耐药机制。
PLoS One. 2012;7(2):e30804. doi: 10.1371/journal.pone.0030804. Epub 2012 Feb 2.
7
Rhodium-catalyzed annulation of N-benzoylsulfonamide with isocyanide through C-H activation.铑催化的 N-苯甲酰磺酰胺与异氰的环化反应通过 C-H 活化。
Chemistry. 2011 Nov 4;17(45):12591-5. doi: 10.1002/chem.201102475. Epub 2011 Oct 4.
8
Etoposide quinone is a redox-dependent topoisomerase II poison.依托泊苷醌是一种依赖于氧化还原的拓扑异构酶 II 毒物。
Biochemistry. 2011 Jun 28;50(25):5660-7. doi: 10.1021/bi200438m. Epub 2011 Jun 2.
9
Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage.依托泊苷衍生物 F14512 与人源拓扑异构酶 II 的相互作用:C4 亚精胺部分促进酶介导的 DNA 断裂的作用机制。
Biochemistry. 2011 Apr 19;50(15):3240-9. doi: 10.1021/bi200094z. Epub 2011 Mar 28.
10
ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.拓扑异构酶IV的ATP结合构象:肺炎链球菌中喹诺酮类药物的一个可能靶点。
J Bacteriol. 2003 Oct;185(20):6137-46. doi: 10.1128/JB.185.20.6137-6146.2003.